Cargando…
Effect of Empagliflozin in Preventing Progression of Renal Dysfunction in Diabetic Patients With Compensated Heart Failure ― Reply ―
Autores principales: | Shirakabe, Akihiro, Matsushita, Masato, Okajima, Fumitaka, Asai, Kuniya, Shimizu, Wataru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180374/ https://www.ncbi.nlm.nih.gov/pubmed/34136714 http://dx.doi.org/10.1253/circrep.CR-21-0048 |
Ejemplares similares
-
Empagliflozin Administration Can Decrease the Dose of Loop Diuretics and Prevent the Exacerbation of Renal Tubular Injury in Patients With Compensated Heart Failure Complicated by Diabetes
por: Shirakabe, Akihiro, et al.
Publicado: (2020) -
Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure
por: Shirakabe, Akihiro, et al.
Publicado: (2018) -
Worsening renal failure in patients with acute heart failure: the importance of cardiac biomarkers
por: Shirakabe, Akihiro, et al.
Publicado: (2019) -
Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
por: Fedson, David S., et al.
Publicado: (2020) -
Association Between Periprocedural Heart Rate Trend and Postprocedural Worsening Heart Failure in Patients Receiving Catheter Ablation for Atrial Fibrillation ― Reply ―
por: Matsuda, Yasuhiro, et al.
Publicado: (2022)